Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase

被引:18
|
作者
Fan, NS
Rank, KB
Poppe, SM
Tarpley, WG
Sharma, SK
机构
[1] UPJOHN CO,UPJOHN LABS,BIOCHEM,KALAMAZOO,MI 49001
[2] UPJOHN CO,UPJOHN LABS,CAN & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
D O I
10.1021/bi9516440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently we demonstrated that the p58 subunit of p68/p58 HIV-2 reverse transcriptase (RT) heterodimer, produced by processing of p68/p68 homodimer with recombinant HIV-2 protease, terminates at Met(484) [Fan, N., et al. (1995) J. Biol. Chem. 270, 13573-13579]. Here we describe purification and characterization of the p68/p58 heterodimer of recombinant HIV-2 RT. It exhibited both RT and RNase H activities, obeyed Michaelis-Menten kinetics, and was competitively inhibited by the DNA chain terminator ddTTP (K-i[app] = 305 +/- 20 nM). The HIV-2 RT-associated RNase H exhibited a marked preference for RNA hydrolysis from a HIV-1 gag-based heteropolymeric RNA/DNA hybrid in the presence of either Mg2+ or Mn2+, compared to the [H-3]poly(rA). poly(dT) or [H-3]poly(rG). poly(dC) homopolymeric substrates. Relative to HIV-1 RT, the RNase H activity of HIV-2 RT was only 5% toward the [H-3]poly(rA) poly(dT) in the presence of Mg2+. The size distribution of products generated from [H-3]poly(rA). poly(dT) by HIV-2 RT-associated RNase H was markedly distinct from that of HIV-1 RT in the presence of Mg2+ Or Mn2+. The p68/p58 HIV-2 RT heterodimer, produced by specific cleavage using HIV-2 protease, should be useful for inhibition and biophysical studies aimed at discovering and designing drugs directed toward HIV-2.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 50 条
  • [31] Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
    Kennedy, Edward M.
    Gavegnano, Christina
    Nguyen, Laura
    Slater, Rebecca
    Lucas, Amanda
    Fromentin, Emilie
    Schinazi, Raymond F.
    Kim, Baek
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (50) : 39380 - 39391
  • [32] Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1
    Herschhorn, A
    Admon, A
    Hizi, A
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1648 (1-2): : 154 - 163
  • [33] Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and moloney murine leukemia virus reverse transcriptase
    Gao, HQ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1097 - 1113
  • [34] Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection
    Sakuragi, Sayuri
    Shioda, Tatsuo
    Sakuragi, Jun-ichi
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 3382 - 3388
  • [35] Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations
    Basavapathruni, Aravind
    Vingerhoets, Johan
    de Bethune, Marie-Pierre
    Chung, Raymond
    Bailey, Christopher M.
    Kim, Jiae
    Anderson, Karen S.
    BIOCHEMISTRY, 2006, 45 (23) : 7334 - 7340
  • [36] Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine
    Lennerstrand, J
    Stammers, DK
    Larder, BA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2144 - 2146
  • [37] Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor
    Pilon, AA
    Lum, JJ
    Sanchez-Dardon, J
    Phenix, BN
    Douglas, R
    Badley, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2687 - 2691
  • [38] Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
    Baertschi, SW
    Cantrell, AS
    Kuhfeld, MT
    Lorenz, LJ
    Boyd, DB
    Jaskunas, SR
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04): : 353 - 362
  • [39] THE GROWTH AND CHARACTERIZATION OF CRYSTALS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REVERSE-TRANSCRIPTASE
    JONES, EY
    STUART, DI
    GARMAN, EF
    GRIEST, R
    PHILLIPS, DC
    TAYLOR, GL
    MATSUMOTO, O
    DARBY, G
    LARDER, B
    LOWE, D
    POWELL, K
    PURIFOY, D
    ROSS, CK
    SOMERS, D
    TISDALE, M
    STAMMERS, DK
    JOURNAL OF CRYSTAL GROWTH, 1993, 126 (2-3) : 261 - 269
  • [40] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236